Characterization of the Entamoeba histolytica Ornithine Decarboxylase-Like Enzyme Novel Drug Target of Entamoeba histolytica
2008

Characterization of a Potential Drug Target in Entamoeba histolytica

publication Evidence: moderate

Author Information

Author(s): Jhingran Anupam, Padmanabhan Prasad K., Singh Sushma, Anamika Krishanpal, Bakre Abhijeet A., Bhattacharya Sudha, Bhattacharya Alok, Srinivasan Narayanaswamy, Madhubala Rentala

Primary Institution: Jawaharlal Nehru University, New Delhi, India

Hypothesis

The study aims to characterize the ornithine decarboxylase-like enzyme in Entamoeba histolytica as a potential drug target.

Conclusion

The molecular characterization of the putative ODC-like enzyme from E. histolytica suggests it has evolved a novel substrate specificity and is not inhibited by DFMO.

Supporting Evidence

  • The putative ODC-like sequence has 33% sequence identity with human ODC.
  • The enzyme is a single-copy gene located on a 1.9-Mb chromosome.
  • DFMO had no effect on the recombinant putative ODC from E. histolytica.
  • Computer modeling revealed critical residues for DFMO binding are substituted in E. histolytica.

Takeaway

Researchers studied a protein in a tiny germ that makes people sick, and they found it might not work like similar proteins in humans, which could help in making new medicines.

Methodology

The gene encoding the putative ornithine decarboxylase-like sequence was cloned, expressed in E. coli, and characterized through various biochemical assays.

Limitations

The recombinant putative ODC was unstable, and the study could not determine its activity with certain substrates.

Digital Object Identifier (DOI)

10.1371/journal.pntd.0000115

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication